Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pituitary Adenoma: SSTR2 rs2236750, SSTR5 rs34037914, and AIP rs267606574 Genetic Variants, Serum Levels, and Ki-67 Labeling Index Associations.

Medicina (Kaunas, Lithuania) - 1 Aug 2024

Gedvilaite-Vaicechauskiene Greta, Kriauciuniene Loresa, Tamasauskas Arimantas, Rovite Vita, Mandrika Ilona, Wu Sheng-Nan, Huang Chin-Wei, Poskiene Lina, Liutkeviciene Rasa

Abstract excerpt

Background and Objectives: This study explores the complex pathogenesis of pituitary adenomas (PAs), prevalent intracranial tumors in the pituitary gland. Despite their generally benign nature, PAs exhibit a diverse clinical spectrum involving hormone hypersecretion and varying invasiveness, hinting at multifaceted molecular mechanisms and abnormalities in tumorigenesis and gene regulation. Materials and Methods:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenoma
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Genotype

Share to Intracellular Signaling Peptides and Proteins

Share to Ki-67 Antigen

Share to Pituitary Neoplasms

Share to Receptors, Somatostatin

Source

Open in PubMed Open full text

Identifiers

PMID: 39202532
DOI: 10.3390/medicina60081252
PMCID: PMC11356775

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pituitary Adenoma: SSTR2 rs2236750, SSTR5 rs34037914, and AIP rs267606574 Genetic Variants, Serum Levels, and Ki-67 Labeling Index Associations.PMID 39202532Read ↗

From Genes to Therapy: Pituitary Adenomas in the Era of Precision MedicineSemantic proximity Read ↗

Validation of a Clinicopathological Classification for Predicting Outcomes of Pituitary Tumours: Retrospective Cohort Study in a Pituitary Tumour Centre of Excellence, 2013–2023Semantic proximity Read ↗

Transcription Factor–Based Classification of Pituitary Neuroendocrine Tumors: Practical Immunohistochemical Algorithms, Molecular Correlates, and Diagnostic Challenges in the 5th WHO EraSemantic proximity Read ↗

Are PTTG1 variants associated with tumor characteristics and p53/Ki-67 expression in pituitary neuroendocrine tumors.Semantic proximity Read ↗

Pituitary Tumors: Genetic and Molecular Factors Underlying Pathogenesis and Clinical BehaviorSemantic proximity Read ↗

Transcriptome and methylome analysis reveals three cellular origins of pituitary tumorsSemantic proximity Read ↗

Signal Transducer and Activator of Transcription 4 (STAT4) Association with Pituitary Adenoma.Semantic proximity Read ↗

MALAT1 rs619586 as a potential genetic marker of pituitary adenoma susceptibility and aggressiveness.Semantic proximity Read ↗

Pituitary tumours: molecular and genetic aspects.Semantic proximity Read ↗

Annotation of pituitary neuroendocrine tumors with genome-wide expression analysisSemantic proximity Read ↗

Aggressive Pituitary TumorsSemantic proximity Read ↗

Clinical integration and application of the 2022 WHO pituitary tumor classificationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.